Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Amplitech Group | AMPG | Apr 17, 2025 | 1.54 | -7.23 |
Amplitude A | AMPL | Apr 17, 2025 | 8.18 | -1.45 |
Amprius Technologies | AMPX | Apr 17, 2025 | 2.14 | -4.89 |
AMREP | AXR | Apr 17, 2025 | 24.55 | +5.41 |
AMTD Digital ADR | HKD | Apr 17, 2025 | 1.94 | 0.00 |
AMTD Idea Group ADR | AMTD | Apr 17, 2025 | 1.01 | -0.98 |
Amtech Systems | ASYS | Apr 17, 2025 | 3.58 | 0.00 |
Amylyx Pharmaceuticals | AMLX | Apr 17, 2025 | 3.98 | +4.19 |
AN2 Therapeutics | ANTX | Apr 17, 2025 | 1.26 | -1.56 |
Analog Devices | ADI | Apr 17, 2025 | 176.27 | +0.19 |
AnaptysBio | ANAB | Apr 17, 2025 | 20.55 | +7.82 |
Anavex Life Sciences | AVXL | Apr 17, 2025 | 8.95 | +1.24 |
Anbio Biotechnology | NNNN | Apr 17, 2025 | 6.61 | 0.00 |
Andretti Acquisition II | POLE | Apr 17, 2025 | 10.16 | +0.03 |
Andretti Acquisition II Unit | POLEU | Apr 17, 2025 | 10.37 | 0.00 |
Anebulo Pharmaceuticals | ANEB | Apr 17, 2025 | 1.01 | -2.88 |
Angel Oak Financial Strategies | FINS | Apr 17, 2025 | 12.91 | -0.46 |
Angel Oak Mortgage REIT | AOMR | Apr 17, 2025 | 7.91 | +1.93 |
Anghami | ANGH | Apr 17, 2025 | 0.56 | -3.76 |
Angi A | ANGI | Apr 17, 2025 | 11.60 | +1.49 |
AngioDynamics | ANGO | Apr 17, 2025 | 9.52 | +0.63 |
Anglogold Ashanti | AU | Apr 17, 2025 | 43.25 | -5.20 |
Anheuser-Busch InBev ADR | BUD | Apr 17, 2025 | 65.63 | +1.53 |
ANI Pharmaceuticals | ANIP | Apr 17, 2025 | 69.21 | +0.01 |
Anika Therapeutics | ANIK | Apr 17, 2025 | 14.02 | +4.08 |
Anixa Biosciences | ANIX | Apr 17, 2025 | 2.72 | -1.09 |
Annaly Capital Management | NLY | Apr 17, 2025 | 17.90 | +1.53 |
Annaly Capital Management F Pref | NLY-F | Apr 17, 2025 | 24.90 | +0.36 |
Annaly Capital Management G Pref | NLY-G | Apr 17, 2025 | 24.19 | +0.80 |
Annaly Capital Management I Pref | NLY-I | Apr 17, 2025 | 25.00 | +1.13 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.